ANTX · AN2 Therapeutics, Inc. · Executive Compensation
$5.61
-0.10 (-1.75%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$192.45M
Shares
37.74M
Volume · Oct 5
299.95K
Avg daily vol (3M)
234.2K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $1,382,985 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $807,080 |
| Lucy Day | Chief Financial Officer | $774,336 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $1,666,117 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $1,057,350 |
| Paul Eckburg | Former Chief Medical Officer | $946,501 |
| Lucy Day | Chief Financial Officer | $812,699 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Board Chair | $3,342,848 |
| Lucy Day | Chief Financial Officer | $1,524,458 |
| Paul Eckburg | Former Chief Medical Officer | $1,453,786 |
| Josh Eizen | Chief Legal Officer and Chief Operating Officer | $1,147,944 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President and Chief Executive Officer | $3,465,533 |
| Paul Eckburg | Chief Medical Officer | $1,393,156 |
| Joshua Eizen | Chief Legal Officer | $1,354,563 |
| Lucy Day | Chief Financial Officer | $1,328,603 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Eric Easom | President, Chief Executive Officer and Director | $1,718,989 |
| Paul Eckburg | Chief Medical Officer | $903,053 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Sarah Williams | Vice President, Controller and Principal Accounting Officer | Appointed | 2026-01-29 |
| Joshua Eizen | Chief Legal Officer and Chief Operating Officer | Appointed | 2024-11-05 |
| Paul Eckburg, M.D. | Chief Medical Officer | Terminated | 2024-08-08 |
| Lucy Day | Principal Accounting Officer | Appointed | 2023-09-08 |